LDK Solar outlook falls below Wall Street view
-
AP
-
1 hour, 49 minutes ago LDK Solar Co., which makes wafers used in solar cells, said Thursday its second-quarter wafer shipments will top an earlier forecast, but sales will come in below Wall Street's expectations.
Business Highlights
-
AP
-
2 hours, 36 minutes ago Employers cut a larger-than-expected 467,000 jobs in June and the unemployment rate climbed to a 26-year high of 9.5 percent. Workers also saw weekly wages fall, suggesting Americans will have little appetite to spend and the economy's road to recovery will be bumpy.
Bleak payrolls report mauls Wall St; volume thin
-
Reuters
-
2 hours, 45 minutes ago Stocks tumbled on Thursday, driving the S&P 500 down to its third-straight weekly loss, as a steeper-than-expected slide in June non-farm payrolls revived caution about economic recovery prospects.
Bleak payrolls report mauls Wall St; volume thin
-
Reuters
-
2 hours, 45 minutes ago Stocks tumbled on Thursday, driving the S&P 500 down to its third-straight weekly loss, as a steeper-than-expected slide in June non-farm payrolls revived caution about economic recovery prospects.
Business events scheduled for the coming week
-
AP
-
Thu 5:31 pm ET MONDAY, July 6 NEW YORK -- The Institute for Supply Management releases its services sector index for June, 10 a.m. EDT.
A. Schulman fiscal 3Q profit rises 5 percent
-
AP
-
Thu 5:22 pm ET A. Schulman Inc., which makes plastic compounds and resins for consumer products and automotive markets, said Thursday its fiscal third-quarter profit rose 5 percent as cost controls offset sinking sales linked to the economic downturn.
Elan, NRG Energy, Boeing are big movers
-
AP
-
Thu 5:02 pm ET Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and Nasdaq Stock Market: NYSE:
J&J buys $1 billion Elan stake, gains Alzheimer's R&D
-
Reuters
-
Thu 4:40 pm ET Johnson & Johnson has agreed to pay $1 billion for an 18.4 percent stake in Irish drugmaker Elan Corp , and will acquire a major stake in Elan's portfolio of experimental drugs to treat Alzheimer's disease.
|